Ultralife Corporation ULBI
15.63 USD +0.01 (+0.03%)
Nov 3, 2026, 3:25 PM EST
15.62 Day range 15.64
4.90 52-week range 15.67
- YTD
- +173.17%
- 1 year
- +124.82%
Analyst view
Price target (mean) 14.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.15 | 0.15 – 0.15 | 0.18 | -16.7% | 40.00M | -10.2% | 1 |
| Next quarter | 0.15 | 0.15 – 0.15 | 0.21 | -28.6% | 48.00M | +14.5% | 1 |
| Current year | 0.57 | 0.57 – 0.57 | 0.52 | +9.6% | 160.60M | +1.2% | 1 |
| Next year | 0.92 | 0.92 – 0.92 | 0.57 | +61.4% | 218.50M | +36.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | Benchmark | Reiterated | Buy | Buy |
| Jun 27, 2024 | Benchmark | Maintained | Buy | Buy |
| Mar 5, 2024 | Benchmark | Maintained | Buy | Buy |
| Aug 8, 2023 | Benchmark | Reiterated | Buy | Buy |
| Mar 26, 2021 | Benchmark | Initiated | — | Buy |
| May 2, 2013 | Ardour Capital | Downgrade | Hold | Reduce |